Alkermes (ALKS) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Alkermes (ALKS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 441.33 Bn | 434.76 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.84 Bn | 357.70 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.34 Bn | 258.65 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.07 Bn | 147.37 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.22 Bn | 44.22 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.24 Bn | 20.70 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.76 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | 167.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.54 Mn |
| Mar 31, 2026 | 166.46 Mn |
| Dec 31, 2025 | 165.61 Mn |
| Sep 30, 2025 | 165.10 Mn |
| Jun 30, 2025 | 165.05 Mn |
| Mar 31, 2025 | 164.85 Mn |
| Dec 31, 2024 | 162.18 Mn |
| Sep 30, 2024 | 161.78 Mn |
| Jun 30, 2024 | 165.89 Mn |
| Mar 31, 2024 | 169.18 Mn |
| Dec 31, 2023 | 166.98 Mn |
| Sep 30, 2023 | 166.71 Mn |
| Jun 30, 2023 | 166.50 Mn |
| Mar 31, 2023 | 166.06 Mn |
| Dec 31, 2022 | 164.38 Mn |
| Sep 30, 2022 | 164.30 Mn |
| Jun 30, 2022 | 164.23 Mn |
| Mar 31, 2022 | 163.21 Mn |
| Dec 31, 2021 | 161.94 Mn |
| Sep 30, 2021 | 161.69 Mn |